Cabergoline and Pramipexole Interaction
Cabergoline and Pramipexole have a potentially harmful interaction with 95% confidence. Do not combine pramipexole with cabergoline or other dopamine agonists. Using two dopamine agonists simultaneously is redundant and significantly increases the risk of excessive dopaminergic stimulation, leading to severe nausea, orthostatic hypotension, impulse control disorders, and potential psychiatric effects. Choose one dopamine agonist and use it at an appropriate dose. Both compounds affect the gonads and pituitary, so monitoring these systems is recommended.
Compound Profiles
Cabergoline
Dopamine Agonist | Prolactin Management
Cabergoline exerts its effects by acting as a potent agonist at dopamine D2 receptors on lactotroph cells in the anterior pituitary gland. Prolactin secretion is tonically inhibited by hypothalamic dopamine acting on these D2 receptors, and cabergoline mimics this inhibitory signal with high affinity and prolonged duration.
View full profilePramipexole
Dopamine Agonist | Prolactin Management Alternative
Pramipexole exerts its prolactin-suppressing effects by acting as a full agonist at dopamine D2 and D3 receptors, with a marked preference for the D3 subtype. In the anterior pituitary, prolactin secretion by lactotroph cells is tonically inhibited by hypothalamic dopamine acting on D2 receptors.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Cabergoline with Pramipexole?
Combining Cabergoline with Pramipexole is not recommended. Do not combine pramipexole with cabergoline or other dopamine agonists. Using two dopamine agonists simultaneously is redundant and significantly increases the risk of excessive dopaminergic stimulation, leading to severe nausea, orthostatic hypotension, impulse control disorders, and potential psychiatric effects. Choose one dopamine agonist and use it at an appropriate dose.
Is Cabergoline and Pramipexole safe together?
This combination carries significant risk. Do not combine pramipexole with cabergoline or other dopamine agonists. Using two dopamine agonists simultaneously is redundant and significantly increases the risk of excessive dopaminergic stimulation, leading to severe nausea, orthostatic hypotension, impulse control disorders, and potential psychiatric effects. Choose one dopamine agonist and use it at an appropriate dose. Consult a healthcare professional before combining.
What are the interactions between Cabergoline and Pramipexole?
Do not combine pramipexole with cabergoline or other dopamine agonists. Using two dopamine agonists simultaneously is redundant and significantly increases the risk of excessive dopaminergic stimulation, leading to severe nausea, orthostatic hypotension, impulse control disorders, and potential psychiatric effects. Choose one dopamine agonist and use it at an appropriate dose. This assessment has 95% confidence and is based on documented research data.
How should I time Cabergoline and Pramipexole?
Cabergoline has a half-life of ~63-69 hours and Pramipexole has a half-life of ~8 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.